Dr. Wolff is a passionate physician who has spent the last 20 years on developing gene therapy approaches for neuromuscular and metabolic diseases. Dr. Wolff developed a remarkable and effective gene therapy technique for muscle tissue. He was recognized by the Harvard Medical Newsletter as one of the Top Ten Medical Advances of 1991 for his research in gene transfer, and applauded Dr. Wolff's work as one of “a few leaps forward that do yield new treatments or fresh insights into the mechanisms of health and disease”.
Dr. Wolff received his B.A. Degree in Chemistry at Cornell University and earned his M.D. at The Johns Hopkins University, School of Medicine. He completed his medical residency and a fellowship in genetics and metabolism at the University of California, San Diego, after which he served as an Assistant Professor for three years. Since joining the University of Wisconsin – Madison in 1988 as an Assistant Professor, he was appointed Director of the Biochemical Genetics Program at the Waisman Center in 1989, advanced to Professor in the departments of Pediatrics and Medical Genetics, and promoted to Director of the entire Clinical and Medical Genetics division in 2001.
Board certified in Pediatrics and Biochemical, Clinical, and Molecular Genetics, Dr. Wolff is an acknowledged leader in the field of gene therapy. Dr. Wolff was a member of the National Institute of Health's Recombinant DNA Advisory Committee from 1997-2000, responsible for oversight of human gene therapy trials. He is an associate editor for Molecular Therapy and is on the editorial board for the journals Human Gene Therapy, Gene Therapy, and Cancer Gene Therapy. Dr. Wolff also serves on the board of the American Society for Gene Therapy.